REQUEST A DEMO
Total
USD $0.00
Search more companies

Pentamedica S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Pentamedica S.A. Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Pentamedica S.A. is based in Ecuador. The head office is in Guayaquil. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The company was established on September 05, 2014. 14 (2023) employees currently work for Pentamedica S.A.. In its most recent financial highlights, the company reported a net sales revenue increase of 24.7% in 2023. A growth of 11.31% was recorded in its total assets. The net profit margin of Pentamedica S.A. decreased by 0.16% in 2023.

Headquarters
Kennedy Solar 11, Plaza Center Piso 3 Bldg. , Floor 304
Guayaquil; Guayas;

Contact Details: Purchase the Pentamedica S.A. report to view the information.

Website: http://www.pentamedica.com.ec

Basic Information
Total Employees:
Purchase the Pentamedica S.A. report to view the information.
Outstanding Shares:
Purchase the Pentamedica S.A. report to view the information.
Registered Capital:
Purchase the Pentamedica S.A. report to view the information.
Incorporation Date:
September 05, 2014
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
99%
Purchase this report to view the information.
1%
Company Performance
Financial values in the chart are available after Pentamedica S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
24.7%
Total operating revenue
23.2%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
21.74%
Total assets
11.31%
Total equity
32.94%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-0.16%
Return on Equity (ROE)
-2.27%
Debt to Equity Ratio
-53.23%
Quick Ratio
-0.07%
Cash Ratio
-0.34%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?